Skip to main content

MARSHALL WACE, LLP

Position in VTRS — Viatris Inc

CIK 1318757 LONDON, X0

Position in VTRS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,336,341
-$112,979,685 QoQ
Shares Held
839,820
-91.0% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#104
of 1,020 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Jun 30, 2026
CallValue
$34,936
CallShares
2,200
PutValue
$11,116
PutShares
700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. VTRS ranks #12 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VTRS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,116 700
2026-06-30 $13,336,341 839,820
2026-06-30 $34,936 2,200
2026-03-31 $126,316,026 9,349,817
2026-03-31 $10,808 800
2026-03-31 $40,530 3,000
2025-12-31 $5,015,594 402,859
2025-09-30 $3,135,062 316,673
2025-06-30 $5,183,480 580,457
2025-03-31 $2,259,844 259,454
2024-12-31 $14,587,813 1,171,712
2024-09-30 $599,273 51,617
2024-06-30 $11,704,703 1,101,101
2023-03-31 $3,494,801 363,285
2022-09-30 $7,215,016 846,833
2022-06-30 $4,113,767 392,910
2022-03-31 $88,021,113 8,090,176
2021-12-31 $32,852,192 2,428,100
2021-09-30 $8,103,685 598,058
2021-09-30 $201,895 14,900
2021-06-30 $3,499,921 244,921
2020-12-31 $877,275 46,813